A Review of Road Traffic-Derived Non-Exhaust Particles: Emissions, Physicochemical Characteristics, Health Risks, and Mitigation MeasuresShow others and affiliations
2022 (English)In: Environmental Science and Technology, ISSN 0013-936X, E-ISSN 1520-5851, Vol. 56, no 11, p. 6813-6835Article, review/survey (Refereed) Published
Abstract [en]
Implementation of regulatory standards has reduced exhaust emissions of particulate matter from road traffic substantially in the developed world. However, nonexhaust particle emissions arising from the wear of brakes, tires, and the road surface, together with the resuspension of road dust, are unregulated and exceed exhaust emissions in many jurisdictions. While knowledge of the sources of nonexhaust particles is fairly good, source-specific measurements of airborne concentrations are few, and studies of the toxicology and epidemiology do not give a clear picture of the health risk posed. This paper reviews the current state of knowledge, with a strong focus on health-related research, highlighting areas where further research is an essential prerequisite for developing focused policy responses to nonexhaust particles.
Place, publisher, year, edition, pages
American Chemical Society (ACS), 2022. Vol. 56, no 11, p. 6813-6835
Keywords [en]
exposure assessment, health effects, mitigation, nonexhaust emissions, road traffic, toxicity
National Category
Environmental Sciences
Identifiers
URN: urn:nbn:se:vti:diva-18797DOI: 10.1021/acs.est.2c01072ISI: 000810684000003PubMedID: 35612468Scopus ID: 2-s2.0-85131702594OAI: oai:DiVA.org:vti-18797DiVA, id: diva2:1698824
Funder
Swedish Transport AdministrationNIH (National Institutes of Health), ES031986NERC - the Natural Environment Research Council, NE/T001909/2Wellcome trust, 209376/Z/17/Z
Note
Research funding also provided by Health Effects Institute, National Institute for Health Research (NIHR), Health Protection Research Unit in Environmental Exposures and Health, UK Health Security Agency, Imperial College, Medical Research Council (Grant No. MR/S0196669/1, 2019–2024), NIHR Imperial Biomedical Research Centre (Grant No. RDR03), NordFoU, Robert Bosch GmbH (Grant No. NE/S013342/2), British Heart Foundation (Grant No. CH/09/002), and Medical Research Council (Grant No. PUAG019).
2022-09-262022-09-262025-09-11Bibliographically approved